Nicholas Bene1, Xing Li2, Sumon Nandi3. 1. Tufts University School of Medicine, Boston, MA, United States. 2. Geisel School of Medicine at Dartmouth, Hanover, NH, United States. 3. Department of Orthopaedic Surgery, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Abstract
BACKGROUND: We aimed to determine if reoperation-free survival following irrigation and debridement (I&D) with head and liner exchange of infected primary THA is affected by: 1) postoperative antibiotic duration; 2) patient characteristics; 3) infecting organism; or 4) postoperative versus hematogenous infection. METHODS: Revision THAs from 2006 to 2012 (n = 1184) were observed; 26 underwent I&D with head and liner exchange with mean 4.1-year follow-up. Patients with reoperation for infection (n = 2) versus those without reoperation (n = 24) were analyzed. RESULTS: Increased postoperative antibiotic therapy duration (p = 0.0333) decreased risk of reoperation for infection. CONCLUSION: Chronic antibiotic suppression should be considered following THA I&D with head and liner exchange.
BACKGROUND: We aimed to determine if reoperation-free survival following irrigation and debridement (I&D) with head and liner exchange of infected primary THA is affected by: 1) postoperative antibiotic duration; 2) patient characteristics; 3) infecting organism; or 4) postoperative versus hematogenous infection. METHODS: Revision THAs from 2006 to 2012 (n = 1184) were observed; 26 underwent I&D with head and liner exchange with mean 4.1-year follow-up. Patients with reoperation for infection (n = 2) versus those without reoperation (n = 24) were analyzed. RESULTS: Increased postoperative antibiotic therapy duration (p = 0.0333) decreased risk of reoperation for infection. CONCLUSION: Chronic antibiotic suppression should be considered following THA I&D with head and liner exchange.
Entities:
Keywords:
Antibiotic; Infection; Irrigation and debridement; Reoperation; Total hip arthroplasty
Authors: Thomas K Fehring; Susan M Odum; Keith R Berend; William A Jiranek; Javad Parvizi; Kevin J Bozic; Craig J Della Valle; Terence J Gioe Journal: Clin Orthop Relat Res Date: 2013-01 Impact factor: 4.176
Authors: D Rodríguez-Pardo; C Pigrau; J Lora-Tamayo; A Soriano; M D del Toro; J Cobo; J Palomino; G Euba; M Riera; M Sánchez-Somolinos; N Benito; M Fernández-Sampedro; L Sorli; L Guio; J A Iribarren; J M Baraia-Etxaburu; A Ramos; A Bahamonde; X Flores-Sánchez; P S Corona; J Ariza Journal: Clin Microbiol Infect Date: 2014-06-14 Impact factor: 8.067
Authors: Susan M Odum; Thomas K Fehring; Adolph V Lombardi; Ben M Zmistowski; Nicholas M Brown; Jeffrey T Luna; Keith A Fehring; Erik N Hansen Journal: J Arthroplasty Date: 2011-05-31 Impact factor: 4.757
Authors: Javad Parvizi; Benjamin Zmistowski; Elie F Berbari; Thomas W Bauer; Bryan D Springer; Craig J Della Valle; Kevin L Garvin; Michael A Mont; Montri D Wongworawat; Charalampos G Zalavras Journal: Clin Orthop Relat Res Date: 2011-11 Impact factor: 4.176
Authors: Andrew J Pugely; Christopher T Martin; Yubo Gao; Marin L Schweizer; John J Callaghan Journal: J Arthroplasty Date: 2015-06-03 Impact factor: 4.757
Authors: C E Marculescu; E F Berbari; A D Hanssen; J M Steckelberg; S W Harmsen; J N Mandrekar; D R Osmon Journal: Clin Infect Dis Date: 2006-01-05 Impact factor: 9.079
Authors: Elie F Berbari; Camelia Marculescu; Irene Sia; Brian D Lahr; Arlen D Hanssen; James M Steckelberg; Rachel Gullerud; Douglas R Osmon Journal: Clin Infect Dis Date: 2007-09-26 Impact factor: 9.079